Liraglutide, a human GLP-1 analogue, significantly improves beta cell function in subjects with type 2 diabetes by Matthews, DR, Marre, M, Le-Thi, T, Zdravkovic, M, Simo, R, Garber, A, Zinman, B

Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes by Mohammedi, K, Woodward, M, Zoungas, S, Q, L, Harrap, Stephen, S, Patel, A, Marre, M, Chalmers, J

Transforming growth factor-beta 1 production is correlated with genetically determined ACE expression in congenic rats: a possible link between ACE genotype and diabetic nephropath... by Pueyo, M, Challah, M, Gauguier, D, Louedec, L, Philippe, M, Gaertner, R, Marre, M, Michel, J, Jacob, M

Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial by Ohkuma, T, Zoungas, S, Jun, M, Lisheng, L, Mancia, G, Marre, M, Rodgers, A, Williams, B, Woodward, M, Chalmers, J

The impact of level of education on vascular events and mortality in patients with type 2 Diabetes mellitus: results from the ADVANCE study by Blomster, J, Zoungas, S, Woodward, M, Neal, B, Harrap, S, Poulter, N, Marre, M, Williams, B, Chalmers, J, Hillis, G

The relationship between plasma 8-OH-deoxyguanosine and cardiovascular disease and survival in type 2 diabetes: results from the ADVANCE study by Thomas, M, Woodward, M, Li, Q, Pickering, R, Tikellis, C, Poulter, N, Cooper, M, Marre, M, Zoungas, S, Chalmers, J

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes by Mohammedi, K, Woodward, M, Marre, M, Colagiuri, S, Cooper, M, Harrap, S, Mancia, G, Poulter, N, Williams, B, Zoungas, S, Chalmers, J

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes by Woodward, M, Mohammedi, K, Hirakawa, Y, Zoungas, S, Williams, B, Lisheng, L, Rodgers, A, Mancia, G, Neal, B, Harrap, S, Marre, M, Chalmers, J

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study by Mohammedi, K, Woodward, M, Hirakawa, Y, Zoungas, S, Colagiuri, S, Hamet, P, Harrap, S, Poulter, N, Matthews, D, Marre, M, Chalmers, J, ADVANCE Collaborative Group

Changes in albuminuria and the risk of major clinical outcomes in diabetes: results from ADVANCE-ON by Jun, M, Ohkuma, T, Zoungas, S, Colagiuri, S, Mancia, G, Marre, M, Matthews, D, Poulter, N, Williams, B, Rodgers, A, Perkovic, V, Chalmers, J, Woodward, M

The canosinase gene (CNDP1) is not a protection factor of diabetic nephropathy in type 1 diabetics by Vionnet, N, Marre, M, Groop, P, Tarnow, L, Lemainque, A, Hadjadj, S, Parving, H, Forsblom, C, Tregouet, D, Farrall, M, Cambien, F, Lathrop, M

Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results From ADVANCE-ON. by Jun, M, Ohkuma, T, Zoungas, S, Colagiuri, S, Mancia, G, Marre, M, Matthews, D, Poulter, N, Williams, B, Rodgers, A, Perkovic, V, Chalmers, J, Woodward, M

Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial by Selvin, E, Wang, D, McEvoy, JW, Juraschek, SP, Lazo, M, Hamet, P, Cooper, ME, Marre, M, Williams, B, Harrap, S, Chalmers, J, Woodward, M

Associations between body mass index and the risk of renal events in patients with type 2 diabetes by Mohammedi, K, Chalmers, J, Herrington, W, Li, Q, Mancia, G, Marre, M, Poulter, N, Rodgers, A, Williams, B, Perkovic, V, Coresh, J, Woodward, M

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial by Welsh, P, Rankin, N, Li, Q, Mark, P, Würtz, P, Ala-Korpela, M, Marre, M, Poulter, N, Hamet, P, Chalmers, J, Woodward, M, Sattar, N

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes by Woodward, M, van der Leeuw, J, Visseren, F, van der Graaf, Y, Grobbee, D, Harrap, S, Heller, S, Mancia, G, Marre, M, Poulter, N, Zoungas, S, Chalmers, J

Severe Hypoglycemia and Risks of Vascular Events and Death by Zoungas, S, Patel, A, Chalmers, J, de Galan, B, Li, Q, Billot, L, Woodward, M, Ninomiya, T, Neal, B, MacMahon, S, Grobbee, D, Kengne, A, Marre, M, Heller, S

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluatio... by van Steen, S, Woodward, M, Chalmers, J, Li, Q, Marre, M, Cooper, M, Hamet, P, Mancia, G, Colagiuri, S, Williams, B, Grobbee, D, DeVries, J, ADVANCE Collaborative Group

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial by Rahman, F, McEvoy, J, Ohkuma, T, Marre, M, Hamet, P, Harrap, S, Mancia, G, Rodgers, A, Rahman, F, Selvin, E, Williams, B, Muntner, P, Chalmers, J, Woodward, M

EURAGEDIC; European consortium for the genetics of diabetic nephropathy: strategy and first results. by Vionnet, N, Gut, I, Matsuda, F, Marre, M, Hadjadj, S, Parving, H, Tarnow, L, Groop, P, Forsblom, C, Gauguier, D, Cox, R, Kazeem, G, Farrall, M, Lathrop, M, Cambien, F